Articles from Evvy

Evvy, leader in vaginal microbiome testing & care, has published the largest real-world outcomes study to date on at-home vaginal healthcare, demonstrating a breakthrough in outcomes for the diagnosis and treatment of bacterial vaginosis (BV). The peer-reviewed study, published in Microorganisms Journal, validates that Evvy’s innovative, personalized approach leads to significantly lower recurrence rates and robust symptom resolution.

Evvy, the precision women’s health company, today announces the launch of its latest innovation: Evvy Women’s Complete Probiotic. This once-daily supplement delivers advanced 3-in-1 microbiome support for gut, vaginal and urinary health — backed by science and uniquely formulated for women.

Evvy, a pioneering women’s health startup focused on the vaginal microbiome, today announced the launch of a landmark clinical study exploring the link between the vaginal microbiome and in vitro fertilization (IVF) outcomes. This will be the first-ever study using a validated, commercially available vaginal microbiome test to uncover potential microbial markers linked to IVF success.

Evvy, the company closing the gender health gap through biomarkers in the vaginal microbiome, is introducing groundbreaking Fertility Insights within its flagship Vaginal Microbiome Test. As the first and only validated, at-home, mNGS vaginal microbiome test, Evvy is now expanding its capabilities to provide science-backed insights on the role of the vaginal microbiome in fertility.

Evvy, a female-founded startup unlocking precision women’s healthcare through biomarker discovery, announced today the closing of a $14 million Series A funding round led by Left Lane Capital. The round also includes General Catalyst, Labcorp Venture Fund, RH Capital, Ingeborg Investments, G9 Ventures, Virtue, and Amboy Street Ventures.